Institution profile

Takeda

Industry researchasia · jp
Official website
Research library2linked papers
Opportunities0open roles
Selected work

Representative Papers

Human-AI Collaboration Increases Efficiency in Regulatory Writing

Sep 10, 2025

Drafting nonclinical summaries for Investigational New Drug (IND) applications is time-intensive and heavily reliant on expert knowledge, impeding early-stage drug development efficiency. Method: We propose AutoIND—a human-in-the-loop platform leveraging large language models (LLMs) to automatically generate draft summaries, coupled with a blinded, multidimensional quality assessment framework evaluating seven criteria: correctness, completeness, consistency, clarity, regulatory compliance, traceability, and coherence. Contribution/Results: AutoIND reduces drafting time by 97% (from 100 hours to 2.6–3.7 hours) while processing reports spanning tens of thousands of pages. Generated drafts achieve quality scores of 69.6%–77.9% and contain no critical regulatory deficiencies. This work represents the first systematic application of LLMs to core IND document generation, empirically validating a high-quality, high-efficiency, and regulatory-compliant AI-augmented authoring paradigm. It delivers a reproducible methodology and practical implementation pathway for intelligent drug development.

0 citationsRead paper
Recent publications

Latest Papers

Human-AI Collaboration Increases Efficiency in Regulatory Writing

Sep 10, 2025

Drafting nonclinical summaries for Investigational New Drug (IND) applications is time-intensive and heavily reliant on expert knowledge, impeding early-stage drug development efficiency. Method: We propose AutoIND—a human-in-the-loop platform leveraging large language models (LLMs) to automatically generate draft summaries, coupled with a blinded, multidimensional quality assessment framework evaluating seven criteria: correctness, completeness, consistency, clarity, regulatory compliance, traceability, and coherence. Contribution/Results: AutoIND reduces drafting time by 97% (from 100 hours to 2.6–3.7 hours) while processing reports spanning tens of thousands of pages. Generated drafts achieve quality scores of 69.6%–77.9% and contain no critical regulatory deficiencies. This work represents the first systematic application of LLMs to core IND document generation, empirically validating a high-quality, high-efficiency, and regulatory-compliant AI-augmented authoring paradigm. It delivers a reproducible methodology and practical implementation pathway for intelligent drug development.

0 citationsRead paper